Related Experiment Videos
Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based
Ewoudt M W van de Garde1, Henrik Endeman, Remco N van Hemert
1Department of Clinical Pharmacy, St. Antonius Hospital, P.O. Box 2500, Nieuwegein, 3430 EM, The Netherlands, e.van.de.garde@antoniusmesosgroep.nl.
Objective:
The causative micro-organism in community-acquired pneumonia (CAP) is often difficult to predict. Different studies have examined chronic morbidity and clinical symptoms as predictors for microbial aetiology of pneumonia. The aim of our study was to assess whether prior outpatient antimicrobial treatment is predictive for determining the microbial aetiology of CAP.
Methods:
This was a hospital-based prospective observational study including all patients admitted with CAP between 1 October 2004 and 1 August 2006. Microbial investigations included sputum, blood culture, sputum PCR, antigen testing and serology. Exposure to antimicrobial drugs prior to hospital admission was ascertained through community pharmacy dispensing records. Multivariate logistic regression analysis was conducted to assess whether prior outpatient antimicrobial treatment is a predictor of microbial aetiology. Patient demographics, co-morbidities and pneumonia severity were considered to be other potential predictors.
Results:
Overall, 201 patients were included in the study. The microbial aetiology was determined in 64% of the patients. The five most prevalent pathogens were Streptococcus pneumoniae, Heamophilus influenzae, Legionella spp., Mycoplasma pneumoniae and Influenza virus A+B. Forty-seven of the patients (23%) had received initial antimicrobial treatment as outpatients. Multivariate analyses revealed that initial outpatient beta-lactam treatment was associated with a threefold increased chance of finding atypical pathogens and a threefold decreased probability of pneumococcal infection; the corresponding odds ratios were 3.51 (95% CI 1.25-9.99) and 0.30 (95% CI 0.10-0.90), respectively. Patients who received macrolides prior to hospitalisation had an increased probability of viral pneumonia.
Conclusion:
Prior outpatient antimicrobial therapy has a predictive value in the diagnostic workup aimed at identifying the causative pathogen and planning corresponding antimicrobial treatment in patients hospitalised for pneumonia.
Insights
Prior outpatient antimicrobial treatment can help predict the cause of community-acquired pneumonia (CAP). This finding aids in diagnosing pneumonia and selecting appropriate antimicrobial therapies for hospitalized patients.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Predicting the causative pathogen in community-acquired pneumonia (CAP) is challenging.
- Previous research explored chronic morbidity and symptoms as predictors.
- The role of prior outpatient antimicrobial treatment in determining CAP etiology requires further investigation.
Purpose of the Study:
- To assess if prior outpatient antimicrobial treatment predicts the microbial etiology of CAP.
- To identify specific antimicrobial classes associated with particular pathogens.
- To inform diagnostic workup and treatment strategies for CAP.
Main Methods:
- Prospective observational hospital-based study (October 2004 - August 2006).
- Included patients admitted with CAP.
- Microbial investigations: sputum, blood culture, PCR, antigen testing, serology.
- Outpatient antimicrobial exposure data from pharmacy records.
- Multivariate logistic regression analysis.
Main Results:
- 201 patients included; etiology determined in 64%.
- Most common pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Legionella spp., Mycoplasma pneumoniae, Influenza A+B.
- 23% received prior outpatient antimicrobial treatment.
- Beta-lactam treatment associated with increased atypical pathogens (OR 3.51) and decreased pneumococcal infection (OR 0.30).
- Macrolide treatment increased probability of viral pneumonia.
Conclusions:
- Prior outpatient antimicrobial therapy is a valuable predictor in diagnosing CAP etiology.
- This information aids in planning targeted antimicrobial treatment.
- Understanding prior treatment influences pathogen identification and patient management.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management